• GS-441524 Workflows for Prodrug Conversion

  2026-08-13

  Build more informative antiviral and pharmacokinetic studies with GS-441524, from DMSO stock preparation to LC–MS/MS tracking across biological matrices. The workflow distinguishes parent-compound activity from prodrug conversion, helping researchers connect cell responses with exposure and metabolite formation.

• COX-2 in Venom-Induced Muscle Ischemia

  2026-08-12

  A Microvascular Research study shows that COX-2 has a time-dependent role after Bothrops asper venom injury: it helps preserve vascular integrity during acute ischemia, whereas early inhibition later enhances angiogenic and matrix-remodeling signals. The findings refine how selective COX-2 inhibition should be interpreted in muscle injury and revascularization models.

• LY2228820: Selective p38 MAP Kinase Inhibitor

  2026-08-12

  LY2228820 is a selective ATP-competitive p38 MAP kinase inhibitor that targets p38α and p38β with nanomolar biochemical potency. It supports mechanistic studies of p38 MAPK signaling, cytokine release, tumor biology, and bortezomib-associated cytotoxicity.

• L. gasseri, NR1I3, and E-Cadherin in Colitis

  2026-08-11

  This study identifies a mechanistic pathway in which Lactobacillus gasseri ATCC33323 protects against DSS-induced colitis by regulating NR1I3-associated CDH1 transcription and preserving E-cadherin-dependent epithelial barrier function. Its combination of probiotic intervention, intestinal E-cadherin loss-of-function models, transcriptional analysis, and in vitro validation provides a stronger causal framework than probiotic efficacy measurements alone.

• Dual Luciferase Reporter Gene System for Gene Regulation

  2026-08-11

  Use a firefly reporter to quantify promoter or enhancer activity while Renilla provides an internal normalization signal in the same sample. The APExBIO K1136 system adds a direct-to-cell workflow, compatible mammalian media, and spectrally distinct readouts for reproducible gene expression regulation studies.

• NBC19 and Metabolic Inflammation: Assay Logic

  2026-08-10

  NBC19 is a nanomolar NLRP3 inflammasome inhibitor for resolving how danger signals shape IL-1β biology. This article connects lactate–HMGB1 signaling in sepsis with practical assay decisions while distinguishing validated product performance from testable research hypotheses.

• Moesin as a Biomarker of Endothelial Injury in Sepsis

  2026-08-09

  The reference study identifies circulating moesin (MSN) as a potential marker of endothelial injury and sepsis severity, linking serum MSN to SOFA scores, procalcitonin, and experimental lung damage. Its combination of patient observations, mouse models, and endothelial-cell mechanistic assays suggests that MSN is both a biomarker candidate and a regulator of ROCK1/MLC and NF-κB-associated barrier dysfunction.

• AMPK–p62 Feedback Under Metabolic Stress

  2026-08-08

  The 2024 Autophagy study identifies a double-positive feedback loop in which AMPK and SQSTM1/p62 reinforce one another during metabolic stress, jointly activating AMPK and NFE2L2/NRF2 antioxidant programs. Its mechanistic model connects lysosomal pH, calcium release, ROS, TFEB/TFE3, TAK1, KEAP1 degradation, and tumor adaptation, while also clarifying why STK11 and KEAP1 pathway alterations can be functionally complementary in NSCLC.

• NF 449 as a Selective P2X1 Antagonist

  2026-08-07

  The reference study identified NF 449 as an exceptionally potent antagonist of recombinant rat P2X1-containing receptors by systematically profiling homomeric and heteromeric P2X channels. Its electrophysiological design established a useful benchmark for distinguishing P2X1-mediated ATP signaling from activity at related receptor subtypes, while also defining the limits of translating recombinant-receptor data to platelet and antithrombotic research.

• Discovery and Characterization of MK 0893 as a Glucagon Rece

  2026-08-07

  The reference study details the rational design and preclinical evaluation of MK 0893, a potent and selective glucagon receptor antagonist. This work provides foundational insights into pharmacophore optimization, selectivity profiling, and in vivo efficacy for type 2 diabetes research.

• BI 2536: Unveiling PLK1 Inhibition for Translational Cancer

  2026-08-06

  This thought-leadership article explores how BI 2536, a potent and selective PLK1 inhibitor, enables advanced mechanistic and translational cancer research. Integrating recent in vitro evaluation paradigms and scenario-driven assay solutions, it delivers strategic guidance for researchers seeking robust, reproducible, and clinically meaningful insights into cell cycle regulation, apoptosis, and tumor biology.

• Antibody Targeting of SCUBE3 Suppresses Cancer Progression

  2026-08-06

  The reference study identifies secretory SCUBE3 as a key driver of cancer growth, therapy resistance, and immune evasion. By developing a neutralizing antibody against SCUBE3, the research demonstrates effective suppression of oncogenic signaling and restoration of antitumor immunity, offering a promising strategy for pan-cancer therapy.

• CARM1-Targeted Peptide Inhibition Suppresses Breast Cancer P

  2026-08-05

  This study introduces a selective peptide inhibitor of CARM1, demonstrating robust suppression of breast cancer cell proliferation both in vitro and in vivo. The findings highlight the therapeutic potential of targeting CARM1 to overcome endocrine resistance and improve outcomes for hormone receptor-positive breast cancer.

• Dual Luciferase Reporter Gene System: Advanced Workflows & I

  2026-08-05

  Unlock precision in gene expression regulation studies with the Dual Luciferase Reporter Gene System. This guide details optimized workflows, troubleshooting strategies, and practical takeaways from cutting-edge cancer research, empowering both high-throughput and mechanistic investigations.

• Hoechst 33342/PI Double Staining Kit: Precision Apoptosis De

  2026-08-04

  The Hoechst 33342/PI Double Staining Kit offers rapid, dual-fluorescent discrimination of apoptosis and necrosis, using cell-permeable and -impermeable dyes for robust cell death characterization. This kit enables accurate chromatin condensation and membrane integrity assessment, supporting advanced research in cell death mechanisms.

7958 records 2/531 page Previous Next 12345 下5页 Last page